• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL CO., INC. NRG TRANSSEPTAL NEEDLE; RF TRANSSEPTAL NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL CO., INC. NRG TRANSSEPTAL NEEDLE; RF TRANSSEPTAL NEEDLE Back to Search Results
Model Number NRG-E-HF-71-C0
Device Problems Device Operates Differently Than Expected (2913); Extrusion (2934)
Patient Problems Perforation (2001); Cardiac Tamponade (2226)
Event Date 01/29/2014
Event Type  Injury  
Event Description
A report was received indicating that cardiac tamponade occurred in pt undergoing a cardiac ablation procedure.This report is being submitted by baylis medical as the nrg transseptal needle was one of the devices used during the procedure.During the procedure, the nrg transseptal needle was used with an sl0 introducer.The slo introducer was not supplied by baylis medical.Prior to rf energy delivery, while the physician was manipulating the devices to try to locate the desired puncture site, the assembly of transseptal devices inadvertently crossed at an unexpected site.No rf energy was applied.The physician confirmed the position of the devices in the left atrium by contrast dye injection, and continued to advance the sheath.At this point, the pt's blood pressure was observed to decrease.Pericardial effusion was then confirmed by echocardiogram.The physician indicated that a cardiac tamponade had occurred and pericardiocentesis was performed.The effusion site could not be identified.The pt prognosis was reported to be well after surgery.There is no evidence to suggest that the nrg needle caused or contributed to the unexpected perforation in the pt, which resulted in the cardiac tamponade.However, as nrg transseptal needle was one of various transseptal devices used in the procedure, baylis medical has decided to submit this report.
 
Manufacturer Narrative
The device was not returned to the mfr for investigation.Perforation is an inherent risk to this type of procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NRG TRANSSEPTAL NEEDLE
Type of Device
RF TRANSSEPTAL NEEDLE
Manufacturer (Section D)
BAYLIS MEDICAL CO., INC.
5959 trans-canada highway
montreal, quebec H4T 1A1
CA  H4T 1A1
Manufacturer Contact
meghal khakhar
2645 matheson blvd. e
mississauga, ontario L4W 5-S4
CA   L4W 5S4
6024875
MDR Report Key3708511
MDR Text Key16011087
Report Number9710452-2014-00003
Device Sequence Number1
Product Code DRC
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K073326
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 03/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2016
Device Model NumberNRG-E-HF-71-C0
Device Catalogue NumberNRG-E-HF-71-C0
Device Lot NumberNGFD090913
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/20/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-